Facility-Specific Employee Influenza Vaccination Data for 2008-09: Options and Considerations for Public Postings Kate Cummings, MPH Healthcare Associated.

Slides:



Advertisements
Similar presentations
CDCs 21 Goals. CDC Strategic Imperatives 1. Health impact focus: Align CDCs people, strategies, goals, investments & performance to maximize our impact.
Advertisements

National Public Health Performance Standards Program Orientation to the Essential Public Health Services.
Agency for Healthcare Research and Quality (AHRQ)
Protocol Development.
Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Improving how your organisation supports the use of research evidence to inform policymaking.
Advanced Health Models and Meaningful Use Workgroup: Roadmap Charge Overview Paul Tang, chair Joe Kimura, co-chair.
How are you going to manage?.  Informal  collection of vendors  loosely managed  minimal structure  Informal  collection of vendors  loosely managed.
Designing an Effective Evaluation Strategy
Supporting & promoting Equality & Diversity through REF Dianne Berry, Chair REF E&D Advisory Panel Ellen Pugh, Senior Policy Officer ECU.
C. difficile Subcommittee Summary HAI Advisory Committee Nov 18, 2010 Submitted by R. Murthy, MD (Subcommittee Chair)
Assessing Disease Frequency
INTRODUCTION HINF 371 Medical Methodologies Session 1.
Rankings: What do they matter, what do they measure? Anne McFarlane August 18, 2010.
The Executive’s Guide to Strategic C H A N G E Leadership.
NIH Mentored Career Development Awards (K Series) Part 4
Quality evaluation and improvement for Internal Audit
Evaluation. Practical Evaluation Michael Quinn Patton.
Bias and errors in epidemiologic studies Manish Chaudhary BPH( IOM) MPH(BPKIHS)
Influenza Vaccination in Employees, California General Acute Care Hospitals Tricia McLendon, MPH Healthcare Associated Infections Program California.
Unit 4: Monitoring Data Quality For HIV Case Surveillance Systems #6-0-1.
Purpose of the Standards
Evaluating Physical Activity Intervention Programs Thomas Schmid, PhD Physical Activity and Health Branch CDC Atlanta, Georgia, USA.
Marketing Research Aaker, Kumar, Day Seventh Edition Instructor’s Presentation Slides.
Continuous Quality Improvement (CQI)
FDA Recalls Risk Communication Advisory Committee David K. Elder Director, Office of Enforcement.
How to Develop the Right Research Questions for Program Evaluation
Influenza Vaccination Coverage Among Healthcare Workers – Maine, 2012 Susan E. Manning, MD, MPH, Sara Robinson, MPH, Stephen D. Sears, MD, MPH Maine Center.
Criteria and Standard.
Sharing and explaining the standardized infection ratio (SIR): Does your audience prefer words, colors, and/or δymβφĨs? Dana Burshell, MPH, CPH, CIC HAI.
Presentation to: Georgia Hospital Association Presented by: Matthew Crist, MD, MPH Date: October 31, 2012 The Path to National Healthcare Surveillance.
Lecture 8 Objective 20. Describe the elements of design of observational studies: case reports/series.
RESEARCH A systematic quest for undiscovered truth A way of thinking
Performance Measurement and Analysis for Health Organizations
FY Division of Human Resources Development Combined COV COV PRESENTATION TO ADVISORY COMMITTEE January 7, 2014.
Where Results Begin. “We don’t have a health care delivery system in this country. We have an expensive plethora of uncoordinated, unlinked, economically.
Aaker, Kumar, Day Eighth Edition Instructor’s Presentation Slides
DrugEpi 1-4 Counting HS Marijuana Use Module 1 Overview Context Content Area: Descriptive Epidemiology & Surveillance Essential Question (Generic): How.
Public Health Surveillance
The Audit Process Tahera Chaudry March Clinical audit A quality improvement process that seeks to improve patient care and outcomes through systematic.
Unit 10. Monitoring and evaluation
Ensuring the quality of Qualitative Data Presented by Lorie Broomhall, Ph.D. Senior HIV/AIDS Advisor Nigeria Monitoring and Evaluation Management Services.
Systematic Reviews.
Patient Protection and Affordable Care Act March 23, 2010.
United States Department of Agriculture Food Safety and Inspection Service 1 National Advisory Committee on Meat and Poultry Inspection August 8-9, 2007.
Module 2: Quality and Quality Measures The degree to which health services for individuals and populations increase the likelihood of desired health outcomes.
Deciding how much confidence to place in a systematic review What do we mean by confidence in a systematic review and in an estimate of effect? How should.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
The Major Steps of a Public Health Evaluation 1. Engage Stakeholders 2. Describe the program 3. Focus on the evaluation design 4. Gather credible evidence.
System error Biases in epidemiological studies FETP India.
Strategic Plan Review Drawing a Picture & Sharing a Story.
Performance Measurement & Public Reporting: Consumer Perspective and Principles To schedule a presentation of “Performance Measurement & Public Reporting”
Guidance Training (F520) §483.75(o) Quality Assessment and Assurance.
State Administration Staffing a report by the Office of Program Evaluation & Government Accountability FINAL REPORT May 2008 FISCAL OPPORTUNIT Y STUDY.
Creating an Integrated Framework for Reducing Disparities in Health Care Quality Francis D. Chesley, Jr., MD Director Office of Extramural Research, Education.
FDA job description  Regulates about 25% of all consumer purchases  Mission summary: protect and advance public health  Products: food, cosmetics, drugs,
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Clinical Trial Design and other Statistical Issues Mary A. Foulkes, Ph.D. Office of Biostatistics and Epidemiology Vaccines and Related Biological Products.
Quality Improvement Tools for Intervention Determination Presenters: Kris Hartmann, MS Healthcare Analyst, Performance Improvement Projects Don Grostic,
Copyright c 2001 The McGraw-Hill Companies, Inc.1 Chapter 5 Research Ethics All researchers, even students, have a responsibility to conduct ethical research.
Lesson 3 Page 1 of 24 Lesson 3 Considerations in Planning Public Health Surveillance.
Quality Measurement A Changing Landscape
Data Collection Methods for Problem Statement
Chapter 5 Research Ethics
MaryCatherine Jones, MPH, Public Health Consultant, CVH Team
What is Social Marketing?
Performance Improvement Projects: PIP Library
Provider Peer Grouping: Project Overview
Presenter: Kate Bell, MA PIP Reviewer
Monitoring and Evaluation in Communication Management
Presentation transcript:

Facility-Specific Employee Influenza Vaccination Data for : Options and Considerations for Public Postings Kate Cummings, MPH Healthcare Associated Infections Program California Department of Public Health

Goals of the Ideal Mandatory Reporting & Disclosure Program 1 Maximize accuracy of data collection Standardize methodology for data collection and analyses Minimize costs to hospitals and governmental agencies Produce data that are valid, fair to hospitals, and useful to consumers 1 Edmond MF In: Hospital Infections, 5 th ed., 2007.

CDC Healthcare Infection Control Practices Advisory Committee (HICPAC) 1 “Mandatory public reporting…is intended to enable stakeholders, including consumers, to make more informed choices on healthcare issues” Public reports must –Convey scientific meaning in a manner that is useful and interpretable to diverse audiences –Must clearly communicate limitations of data and methods –Data should be assessed for validity/precision prior to release 1 Guidance on public reporting of health-care associated infections: Recommendations of the Healthcare Infection Control Practices Advisory Committee Am J Infect Control 2005;33:217-26

Selected Assumptions Underlying Public Reporting 1 Publicly reported healthcare quality data are valid Consumers will use publicly reported data Consumers are willing and able to change their site of care Consumers who use publicly reported data will make decisions that will improve their care Market forces derived from public reporting will provide incentive for hospitals to improve quality Positive outcomes will outweigh negative unintended consequences 1 Edmond MB, Bearman GML, Mandatory Reporting in the US, an Example to Follow? J Hosp Infect 2007Jun;65 (2):182-8.

Opportunities Vaccination of health care personnel has been proven effective 1 The measure is unambiguous 1 ; does not require risk adjustment Public reporting may increase vaccination rates (no published information on effectiveness) 1 Guidance on public reporting of health-care associated infections: Recommendations of the Healthcare Infection Control Practices Advisory Committee Am J Infect Control 2005;33:217-26

Potential constraints “ Developers of reporting systems should avail themselves to established and proven methods of collecting and reporting surveillance data…… publicly reported HAI rates can mislead stakeholders if inaccurate information is disseminated….” 1 Guidance on public reporting of health-care associated infections: Recommendations of the Healthcare Infection Control Practices Advisory Committee Am J Infect Control 2005;33:217-26

What is Surveillance? The ongoing systematic collection and analysis of data and the provision of that information for use in disease prevention and control.

Established surveillance methods Clear goal (s) Clear, uniform case definition (s) Case ascertainment (case-finding) with consistent inclusion and exclusion criteria Consistent surveillance catchments (population under study) Standardized data collection and reporting instruments Data quality assurance Analytic strategies that address limitations to ensure appropriate interpretation Disseminate results

Interpreting Facility-Specific Comparisons Once posted, consumers must consider whether facility-specific percentages differ: –Distortion (systematic error) –Chance (precision) –Truly different Present percentages in a way that discloses potential limitations and allows appropriate interpretation

Option 1: Publicly Post a Report of State Level Data, Only Does not draw attention to facility-specific rates but overall picture of the state –Data are older - may not represent the facility real time; limitations may affect validity Less likely to have unintended consequences associated with inaccurate information No access to facility-specific rates to inform healthcare decisions –Are consumers likely to use reported data to make healthcare decisions? –Are consumers able to choose site of care? No public/market forces to provide incentive for hospitals to report accurate, timely data or improve vaccination rates ProsCons

Option 2: Publicly Post Facility-Specific Data Listed in Alphabetical Order Access to facility-specific rates to inform healthcare decisions May create public/market forces to provide incentive for hospitals to report accurate, timely data or improve vaccination rates Because of data limitations, positive outcomes may not outweigh negative unintended consequences –Data limitations become amplified at the facility-specific level –Example: misclassification can falsely decrease or increase the rate –Inaccurate data may mislead consumers ProsCons

Option 3: Publicly Post Facility-Specific Data Listed in Rank Order By Percentage Vaccinated Rank is clear including outliers Target goals or benchmarks are noted –California average –The Healthy People 2010: 60% –The proposed HP 2020: 90% Facility rates to inform healthcare decisions May create public/market forces to provide incentive for hospitals to report accurate, timely data or improve vaccination rates Attention to outlier facilities –May be misclassified as an outlier in either tale due to data limitations previously described Because of data limitations, positive outcomes may not outweigh negative unintended consequences ProsCons

Option 4: Publicly Post No Data Ensures no unintended consequences associated with reporting inaccurate information Consumers and other stakeholders will have no information No public/market forces to provide incentive for hospitals to report accurate, timely data or improve vaccination rates ProsCons

The data were not collected using established surveillance methodology and may not be valid –Data limitations impact facility rates; this affects our options for public reporting –Opportunities outweighed by potentially harmful unintended consequences? misleading consumers, misdirecting quality improvement efforts, loss of credibility and public trust, diversion from true mission Strongly consider releasing only aggregate data with full disclosure of limitations without specifying facility specific rates Future data must be collected using standardized methodology Given limitations, consider using as a test year; use lessons learned to plan for future data Summary